No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says

Published Date: 30 Sep 2024

Despite problematic dataset, risk/benefit profile not favorable with PD-L1 expression below 1

Read Full News

Latest News



Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Examines Office-Based Transperineal Prostate Biopsies Methodology.

2.

Atezolizumab Consolidation Impresses in High-Risk DLBCL

3.

AI could help improve early detection of interval breast cancers

4.

Study confirms safety and efficacy of higher-dose-per-day radiation for early-stage prostate cancer

5.

Study identifies new target for obesity-related breast cancer


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot